Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    STARGARDT
Show Display Options
Rank Status Study
1 Not yet recruiting Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Conditions: Stargardt Disease;   Diabetic Retinopathy;   Macular Degeneration (Age Related)
Intervention: Other: Anterior Chamber Tap
2 Recruiting Phase I/IIa Study of SAR422459 in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: SAR422459
3 Terminated Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease
Condition: Stargardt Disease
Intervention:
4 Active, not recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Condition: Stargardt Disease
Intervention:
5 Enrolling by invitation A Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: SAR422459
6 Active, not recruiting The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
Condition: Stargardt Disease
Intervention:
7 Completed Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
8 Active, not recruiting Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
9 Recruiting Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Conditions: Stargardt Disease;   Stargardt Macular Degeneration;   Stargardt Macular Dystrophy;   Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
Interventions: Drug: ALK-001;   Drug: Placebo
10 Active, not recruiting A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: hESC-RPE
11 Unknown  Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
12 Completed Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
13 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
14 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
15 Active, not recruiting DHA Supplementation in Patients With STGD3
Condition: Dominantly Inherited Stargardt's Disease (STGD3)
Intervention: Dietary Supplement: Over the counter DHA/EPA dietary supplementation
16 Active, not recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
17 Recruiting Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Conditions: Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention: Procedure: Subretinal transplantation
18 Recruiting Rod and Cone Mediated Function in Retinal Disease
Conditions: Retinal Degeneration;   Retinitis Pigmentosa;   Stargardt's Disease
Intervention:
19 Completed Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Conditions: Stargardt Disease;   Age-related Macular Degeneration;   Other Retinal Dystrophies
Intervention: Drug: ALK-001 (No generic name)
20 Recruiting Stem Cell Therapy for Outer Retinal Degenerations
Conditions: Age Related Macular Degeneration;   Stargardt's Disease;   Exudative Age-related Macular Degeneration
Interventions: Procedure: injection of hESC-RPE in suspension;   Procedure: injection hESC-RPE seeded in a substrate

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.